Protease-activated receptor 2 mediates mucus secretion in the airway submucosal gland

Hyun Jae Lee1, Yu-Mi Yang, Kyubo Kim

  • 1Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.

Plos One
|August 24, 2012
PubMed

Insights

Protease-activated receptor 2 (PAR2) activation triggers mucus secretion in human airways. This calcium-dependent process in airway glands is independent of cystic fibrosis transmembrane conductance regulator function.

Area of Science:

  • Respiratory Medicine
  • Cellular Biology
  • Gastroenterology

Background:

  • Protease-activated receptor 2 (PAR2) is a G protein-coupled receptor found in airway epithelia and smooth muscle.
  • PAR2 is implicated in the pathogenesis of airway inflammation.

Purpose of the Study:

  • To investigate the role of PAR2 in inducing mucus secretion from human airway glands.
  • To elucidate the underlying molecular mechanisms of PAR2-mediated mucus secretion.

Main Methods:

  • Dissection of human, porcine, and murine airway tissues containing submucosal glands.
  • Visualization and quantification of glandular secretions using optical monitoring in a physiological chamber.
  • Measurement of intracellular calcium ([Ca(2+)](i)) using Fura2-AM and spectrofluorometry.
  • Assessment of PAR2-AP effects in wild-type and cystic fibrosis transmembrane conductance regulator (CFTR) mutant mice, including PAR-2 knockouts.

Main Results:

  • PAR2 activation by PAR2-activating peptide (PAR2-AP) stimulated mucus secretion in human airway glands, increasing intracellular calcium.
  • The PAR2-AP-induced secretion in human airways reached approximately 30% of the carbachol response.
  • Porcine airway glands showed heightened sensitivity to PAR2-AP, with responses dependent on calcium and anion secretion.
  • PAR2-AP induced significant mucus secretion in both wild-type and ΔF508 CFTR mutant mice, but not in PAR-2 knockout mice.

Conclusions:

  • PAR2-AP acts as a potent agonist for mucus secretion from airway glands.
  • The mechanism of PAR2-mediated mucus secretion is calcium-dependent.
  • This secretory pathway is independent of cystic fibrosis transmembrane conductance regulator (CFTR) function.

Related Concept Videos

Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Mucosal Barrier of the Stomach01:25

Mucosal Barrier of the Stomach

The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Antiasthma Drugs: Muscarinic Receptor Antagonists01:20

Antiasthma Drugs: Muscarinic Receptor Antagonists

Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Exocrine Glands: Types of Secretions01:13

Exocrine Glands: Types of Secretions

Exocrine glands produce and release a variety of glandular products. Exocrine glands can be classified into serous, mucous, or mixed types based on their secretory products.
Serous glands produce watery secretions rich in digestive enzymes and proteins. The constituent cells of the serous gland have centrally located nuclei and eosinophilic secretory granules in the cytoplasm. The parotid gland is an example of a serous gland. It secretes saliva, which contains enzymes, such as lipases and...